Singh, Mansi
Dhir, Sanjay
Kasar, Jayendra
Smith, Lisa
Choudhury, Ranjan
Tondak, Navya
Funding for this research was provided by:
PATH Fund
Article History
Received: 22 November 2024
Accepted: 21 October 2025
First Online: 12 November 2025
Declarations
:
: The study adhered to the Declaration of Helsinki. This study received ethics approval from the Western Copernicus Group Institutional Review Board (WCG IRB Tracking Number: 20235125) on 28th November 2023. The IRB was in full compliance with Good Clinical Practices, FDA regulations, HHS regulations, and ICH guidelines. All participants provided informed consent before participating in the study. A detailed consent form, titled " Informed Consent Document”, was approved by the WCG IRB on 28th November 2023 and used during data collection. This includes a clear explanation of the study’s purpose, risks, and confidentiality measures. This document has been uploaded with supplementary documents.
: Not applicable.
: The authors declare no competing interests.